Lukang Pharmaceutical announced on August 7 that its holding subsidiary Saite received the “Drug Supplement Application Approval Notice” for amikacin sulfate injections issued by the State Drug Administration.

Zhitongcaijing · 2d ago
Lukang Pharmaceutical announced on August 7 that its holding subsidiary Saite received the “Drug Supplement Application Approval Notice” for amikacin sulfate injections issued by the State Drug Administration.